One of the central mechanisms by which GLP-1 RAs may benefit patients with HS is through systemic metabolic modulation
Weak sales could be attributed to the increased immunogenicity and reduced therapeutic benefit offered by Tanzeum, with efficacy parameters trailing behind Victoza [122]
But coverage of weight loss treatments is less widespread, and navigating the complex insurance landscape can be challenging for patients and time consuming for doctors who prescribe the medications
Consider this scenario: a patient is taking bupropion for depression and has lost a few pounds as a side effect, but their weight loss goals are more significant than what bupropion alone can deliver
That way we can navigate whether side effects are something where we should stop the medication or decrease that medication
With Foundayo, Ro is also tapping into anticipated patient interest in pill-based alternatives that may reduce barriers associated with injections, including convenience and perceived stigma